Trending stocks today
Regeneron Pharmaceuticals Inc (REGN-Q)
NASDAQ:REGN
901.27
7.13
(0.80%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
Related posts
TSX hits Yuletide highBOC holds rate, TSX climbsTSX flat, Wall Street declines on hot employment numbersThis summary was created by AI, based on 5 opinions in the last 12 months.
Regeneron Pharmaceuticals Inc, symbol REGN-Q, has received mixed reviews from experts. Some analysts have upgraded the stock and see potential for future growth, citing a strong pipeline and momentum. Others have expressed concerns about waning momentum and delays in drug approval. However, the consensus is that the company is a quality science company with potential. The stock is currently trading at a reasonable valuation, and while there are some short-term challenges, the long-term outlook remains positive.
N/A
Owned
The momentum is waning, and last quarter revenue growth was only 14%. They're coming to the end of the road.
Shares are down in the past 24 hours due to a delay in a drug approval. But another drug remains strong in sales, and they have double-digit in oncology drugs in trials. A great science company.
A quality company. Trades at 17x. The FDA is delaying approval of a drug, but that is correctable because the issue isn't about safety or efficacy.
Trades at 19x earnings, but have a huge drug pipeline.
Regeneron Pharmaceuticals Inc(REGN-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 4
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 5
Regeneron Pharmaceuticals Inc(REGN-Q) Frequently Asked Questions
What is Regeneron Pharmaceuticals Inc stock symbol?
Regeneron Pharmaceuticals Inc is a American stock, trading under the symbol REGN-Q on the NASDAQ (REGN). It is usually referred to as NASDAQ:REGN or REGN-Q
Is Regeneron Pharmaceuticals Inc a buy or a sell?
In the last year, 5 stock analysts published opinions about REGN-Q. 4 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Regeneron Pharmaceuticals Inc.
Is Regeneron Pharmaceuticals Inc a good investment or a top pick?
Regeneron Pharmaceuticals Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Regeneron Pharmaceuticals Inc.
Why is Regeneron Pharmaceuticals Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Regeneron Pharmaceuticals Inc worth watching?
5 stock analysts on Stockchase covered Regeneron Pharmaceuticals Inc In the last year. It is a trending stock that is worth watching.
What is Regeneron Pharmaceuticals Inc stock price?
On 2024-04-17, Regeneron Pharmaceuticals Inc (REGN-Q) stock closed at a price of $901.27.
An analyst upgraded this to $1,025, a very long way to go. He's gained 40% in this himself. It's reasonable at a 24x PE and enjoys momentum. Sees nothing to derail this.